swisschems semaglutide FDA warns companies over unapproved weight loss drug sales Peptide injections are the hottest

The $62 million in GLP-1 weight loss spending for 2023 accounted for more than 5% of total customer pharmacy costs for BCBSM and BCN Large Group fully insured members

Please request a consultation online or call our office at (734) 712-2323 to get started.

This collaborative approach between your hepatologist and PlexusDx protects your safety while pursuing weight loss benefits

We are witnessing important innovations in medically-supervised weight loss, Sesame co-founder and CEO David Goldhill said in the press release

Your exact macros should be based on your body, goals, activity, medical history, and progress

Compounded Drugs: Compounded drugs used to microdose are not approved by the FDA, making them less safe